SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (4802)7/12/1998 11:01:00 AM
From: Brander  Read Replies (2) of 7041
 
I posted this yesterday, and have received several requests. If anyone else wants a fax of the relevant parts, send me you name and fax number through private message.

There was some discussion on this thread a few days ago about literature that Pfizer put out and Vasomax. This is true; it was mailed out to physicians, and I received it recently.

The publication was about treatment of ED. It was published by Pfizer. It is currently in my office, so I can't quote it. However, it divides the treatment options up into first line, second line, and third line.
Viagra (of course) was listed as a first line treatment. Interestingly, Vasomax was too. There was one other that was listed as first line, but I can't remember what it was. The article stated that Vasomax was moderately effective for treating ED with few side effects (stuffy nose and flushing). MUSE was listed as a second or third line treatment.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News